二尖瓣狭窄

Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol. 1991;61:131-142.

• 摘要

Fawzy ME, Choi WB, Mimish L, et al. Immediate and long-term effect of mitral balloon valvotomy on left ventricular volume and systolic function in severe mitral stenosis. Am Heart J. 1996;132:356-360.

• 摘要

Martin RP, Rakowski H, Kleinman JH. Reliability and reproducibility of two-dimensional echocardiographic measurement of the stenotic mitral valve orifice area. Am J Cardiol. 1979;42:560-568.

• 摘要

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-e643.

• 全文
• 摘要

Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilation. Br Heart J. 1988;60:299-308.

• 全文
• 摘要

Reyes VP, Raju Bs, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994;331:961-967.

• 全文
• 摘要

Subbarao KS, Nachiappan M, Irineu AP. Transventricular mitral commissurotomy in critical mitral stenosis during pregnancy. Asian Cardiovasc Thorac Ann. 2004;12:233-235.

• 摘要

Palacios IF, Sanchez PL, Harrell LC, et al. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105:1465-1471.

• 全文
• 摘要

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-3128.

• 全文
• 摘要

1.  World Health Organization. Rheumatic fever and rheumatic heart disease. WHO Technical Report Series 764. Geneva: World Health Organization; 1998.

2.  Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991;10(10 Suppl):S25-S27.

• 摘要

3.  Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol. 1991;61:131-142.

• 摘要

4.  Smoot JC, Barbian KD, Van Gompel JJ, et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA. 2002;99:4668-4673.

• 全文
• 摘要

5.  Tandon R, Sharma M, Chandrashekhar Y, et al. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol. 2013;10:171-177.

• 摘要

6.  Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-437.

• 全文
• 摘要

7.  Krasuski RA, Bush A, Kay JE, et al. C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J. 2003;146:1099-1104.

• 摘要

8.  Heller SJ, Carelton RA. Abnormal left ventricular contraction in patients with mitral stenosis. Circulation. 1970;42:1099-1119.

• 摘要

9.  Mohan JC, Khalilullah M, Arora R. Left ventricular intrinsic contractility in pure rheumatic mitral stenosis. Am J Cardiol. 1989;64:240-242.

• 摘要

10.  Hilder FJ, Javier RP, Cohen LS, et al. Myocardial dysfunction associated with valvular heart disease. Am J Cardiol. 1972;30:319-326.

• 摘要

11.  Gash AK, Carabello BA, Cepin D, et al. Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis. Circulation. 1983;67:148-154.

• 摘要

12.  Fawzy ME, Choi WB, Mimish L, et al. Immediate and long-term effect of mitral balloon valvotomy on left ventricular volume and systolic function in severe mitral stenosis. Am Heart J. 1996;132:356-360.

• 摘要

13.  Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995 Oct;96(4 Pt 1):758-64.

• 摘要

14.  Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart. 2000;83:721-725.

• 全文
• 摘要

15.  Gardin JM, Schumacher D, Constantine G, et al. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. JAMA. 2000;283:1703-1709.

• 全文
• 摘要

16.  Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424-1430.

• 摘要

17.  Kyle RA. Amyloidosis. Circulation. 1995;91:1269-1271.

• 全文
• 摘要

18.  Martin RP, Rakowski H, Kleinman JH. Reliability and reproducibility of two-dimensional echocardiographic measurement of the stenotic mitral valve orifice area. Am J Cardiol. 1979;42:560-568.

• 摘要

19.  Gorlin R, Gorlin SG. Hydraulic formula for calculation of area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41:1-29.

• 摘要

20.  American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992 Oct 21;268(15):2069-73. [Erratum in: JAMA. 1993 Jan 27;269(4):476.]

• 摘要

21.  Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-e643.

• 全文
• 摘要

22.  Wilkins GT, Weyman AE, Abascal VM, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilation. Br Heart J. 1988;60:299-308.

• 全文
• 摘要

23.  Reyes VP, Raju Bs, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994;331:961-967.

• 全文
• 摘要

24.  Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation. 1998;97:245-250.

• 全文
• 摘要

25.  Cardoso LF, Grinberg M, Rati MA, et al. Comparison between percutaneous balloon valvuloplasty and randomized study. Cardiology. 2002;98:186-190.

• 摘要

26.  Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407-416.

• 摘要

27.  Henriquez DD, Roos-Hesselink JW, Schalij MJ, et al. Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome. Cochrane Database Syst Rev. 2011;(5):CD008128.

• 摘要

28.  Subbarao KS, Nachiappan M, Irineu AP. Transventricular mitral commissurotomy in critical mitral stenosis during pregnancy. Asian Cardiovasc Thorac Ann. 2004;12:233-235.

• 摘要

29.  Palacios IF, Sanchez PL, Harrell LC, et al. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105:1465-1471.

• 全文
• 摘要

30.  Cannan CR, Nishimura RA, Reeder GS, et al. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol. 1997;29:175-180.

• 摘要

31.  Roy SB, Gopinath N. Mitral stenosis. Circulation. 1968;38(suppl):68-76.

• 摘要

32.  Schumacher B, Luderitz B. Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol. 1998;82:29N-36N.

• 摘要

33.  Kellogg F, Liu CK, Fishman IW, et al. Systemic and pulmonary emboli before and after mitral commissurotomy. Circulation. 1961;24:263-266.

• 摘要

34.  Levine HJ, Pauker SG, Eckman MH. Antithrombotic therapy in valvular heart disease. Chest. 1995;108(4 Suppl):360S-370S.

• 摘要

35.  Chiang CW, Lo SK, Ko YS, et al. Predictors of systemic embolism in patients with mitral stenosis: a prospective study. Ann Intern Med. 1998;128:885-889.

• 摘要

36.  Pérez-Gómez F, Salvador A, Zumalde J, et al. Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. Eur Heart J. 2006;27:960-967.

• 全文
• 摘要

37.  Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-3128.

• 全文
• 摘要